Louisiana State Employees Retirement System - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Louisiana State Employees Retirement System ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$61,583
+30386.6%
87,600
-1.9%
0.00%
-66.7%
Q4 2022$202
-99.9%
89,300
-0.2%
0.01%
-25.0%
Q3 2022$286,000
-15.6%
89,500
-0.7%
0.01%
-11.1%
Q2 2022$339,000
-18.9%
90,100
+0.4%
0.01%
-10.0%
Q1 2022$418,000
-65.3%
89,700
+0.4%
0.01%
-61.5%
Q4 2021$1,206,000
+43.2%
89,300
+90.4%
0.03%
+30.0%
Q3 2021$842,000
+3.7%
46,900
-0.8%
0.02%0.0%
Q2 2021$812,000
-14.2%
47,3000.0%0.02%
-20.0%
Q1 2021$946,000
+24.1%
47,300
+5.6%
0.02%
+13.6%
Q4 2020$762,000
+2.7%
44,800
+0.2%
0.02%
-35.3%
Q3 2020$742,000
-27.8%
44,700
+0.7%
0.03%
-44.3%
Q2 2020$1,028,000
+35.3%
44,400
+4.2%
0.06%
+10.9%
Q1 2020$760,000
-17.4%
42,6000.0%0.06%
+19.6%
Q4 2019$920,000
+214.0%
42,600
+389.7%
0.05%
+206.7%
Q2 2019$293,000
-5.2%
8,700
-5.4%
0.02%0.0%
Q1 2019$309,000
+3.3%
9,200
+1.1%
0.02%
-11.8%
Q4 2018$299,000
-51.5%
9,100
-9.9%
0.02%
-34.6%
Q3 2018$616,000
+32.8%
10,100
+6.3%
0.03%
+23.8%
Q2 2018$464,000
-55.4%
9,500
-3.1%
0.02%
-56.2%
Q1 2018$1,041,000
-74.3%
9,800
-85.5%
0.05%
-73.9%
Q4 2017$4,043,000
+166.2%
67,700
+7.0%
0.18%
+159.2%
Q3 2017$1,519,000
+22.9%
63,300
+0.2%
0.07%
+16.4%
Q2 2017$1,236,000
-16.0%
63,200
+0.8%
0.06%
-17.6%
Q1 2017$1,472,000
+95.5%
62,700
+2.1%
0.07%
+89.7%
Q4 2016$753,000
-27.5%
61,400
+1.7%
0.04%
-29.1%
Q3 2016$1,038,000
+21.0%
60,400
+0.2%
0.06%
+22.2%
Q2 2016$858,000
+3.6%
60,300
+0.2%
0.04%
+4.7%
Q1 2016$828,000
-16.7%
60,200
+2.0%
0.04%
-14.0%
Q4 2015$994,000
+55.6%
59,000
+1.2%
0.05%
+51.5%
Q3 2015$639,000
-12.6%
58,300
-0.2%
0.03%
-5.7%
Q2 2015$731,00058,4000.04%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Monaco Asset Management SAM 4,809,601$2,864,5980.85%
Lynx1 Capital Management LP 1,766,815$1,052,3150.70%
CM Management, LLC 800,000$476,4800.51%
Deep Track Capital, LP 18,400,000$10,959,0400.42%
TANG CAPITAL MANAGEMENT LLC 3,939,600$2,346,4260.33%
Acuitas Investments, LLC 721,460$429,7020.25%
RA Capital Management 18,700,000$11,137,7200.22%
GSA CAPITAL PARTNERS LLP 1,841,078$1,0970.09%
UBS OCONNOR LLC 1,376,249$820,2440.02%
Marquette Asset Management, LLC 148,378$88,3740.02%
View complete list of NEKTAR THERAPEUTICS shareholders